Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.79)
# 3,367
Out of 5,138 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $32.64 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $30.41 | +126.08% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.52 | +360.53% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.64 | +2,234.27% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.66 | +21,586.75% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $102.59 | -65.88% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $16.81 | +197.44% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $2.75 | +55,172.73% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.20 | +1,180.49% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $36.63 | -20.83% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.97 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.64
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $30.41
Upside: +126.08%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.52
Upside: +360.53%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.64
Upside: +2,234.27%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.66
Upside: +21,586.75%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $102.59
Upside: -65.88%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $16.81
Upside: +197.44%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $2.75
Upside: +55,172.73%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.20
Upside: +1,180.49%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $36.63
Upside: -20.83%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.97
Upside: -